Top

Indian Journal of Pediatrics

Published in:

01-05-2011 | Original Article

Role of Vasoactive Intestinal Peptide in Hyperoxia-Induced Injury of Primary Type II Alveolar Epithelial Cells

Authors: Xiaoxiao Ao, Fang Fang, Feng Xu

Published in: Indian Journal of Pediatrics | Issue 5/2011

Abstract

Objective

We investigated the effect of VIP on primary type II alveolar epithelial cells (AECIIs) upon the exposure of hyperoxia.

Methods

AECIIs were isolated and purified from premature rats and exposed to air (21% oxygen), hyperoxia(95% oxygen), VIP+air and VIP+hyperoxia, respectively. The proliferation and apoptosis of AECIIs were detected by MTT cell proliferation assay, flow cytometry and western blot. The production of intracellular reactive oxygen species (ROS) was determined by 2 ', 7'-dichloro-dihydrotestosterone fluorescein diacetate (DCFH-DA) molecular probe and the total antioxidant capacity (TAOC) by ultraviolate spectro-photometer.

Results

Cell proliferation significantly increased and apoptosis decreased upon the treatment with VIP. In addition, the level of ROS in the hyperoxia+VIP group was significantly lower than in the hyperoxia group, in contrast, TAOC was higher in the hyperoxia+VIP group than that in the hyperoxia group.

Conclusions

VIP exerts a protective role in the hyperoxia-induced oxidative stress damage in AECIIs, which probably attributed to its anti-oxidant and anti-apoptosis property.

Altemeier WA, Sinclair SE. Hyperoxia in the intensive care unit: why more is not always better. Curr Opin Crit Care. 2007;13(1):73–8.PubMedCrossRef

Pagano A, Barazzone-Argiroffo C. Alveolar cell death in hyperoxia-Induced lung injury. Ann NY Acad Sci. 2003;1010:405–16.PubMedCrossRef

Miyake Y, Kaise H, Isono K, Koseki H, Kohno K, Tanaka M. Protective role of macrophages in noninflammatory lung injury caused by selective ablation of alveolar epithelial type II cells. J Immunol. 2007;178:5001–9.PubMed

Mantell LL, Lee PJ. Signal transduction pathway in hyperoxia-induced lung cell death. Mol Genet Metab. 2000;71:359–70.PubMedCrossRef

Onoue S, Yamada S, Yajima T. Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma/COPD. Peptides. 2007;28:1640–50.PubMedCrossRef

Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H. Pituitary adenylate cyclase activating polypeptide and its receptors: from structure to functions. Pharmacol Rev. 2000;52:269–324.PubMed

Howard DJ, Briggs LA, Pritsos CA. Oxidative DNA damage in mouse heart, liver, and lung tissue due to acute sidestream tobacco smoke exposure. Arch Biochem Biophys. 1998;352:293–7.PubMedCrossRef

Dobbs LG, Gonzalez R, Williams MC. An improved method for isolating type II cells in high yield and purity. Am Rev Respir Dis. 1986;134(1):141–5.PubMed

Foschino Barbaro MP, Carpagnano GE, Spanevello A, Cagnazzo MG, Barnes PJ. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease. Int J Immunopathol Pharmacol. 2007;20:753–63.PubMed

10.

Jiang J, Xu F, Chen J. Repair, survival and apoptosis of type II alveolar epithelial cells and the change of bcl-2/p53 in oxidative stress. Zhonghua Er Ke Za Zhi. 2008;46:74–5.PubMed

11.

Fattman CL. Apoptosis in pulmonary fibrosis: too much or not enough? Antioxid Redox Signal. 2008;10:379–85.PubMedCrossRef

12.

Said SI. Anti-inflammatory actions of VIP in the lungs and airways. In: Said SI, editor. Pro-Inflammatory and Anti-Inflammatory Peptides. (Vol. 112 in Lung Biology in Health and Disease. C Lenfant, Exec. Editor). New York: Marcel Dekker; 1998. p. 345–61.

13.

Said SI. Protection by VIP and Related Peptides against Cell Death and Tissue Injury. Ann NY Acad Sci. 2000;921:264–74.PubMedCrossRef

14.

Leroux P, Vaudry H, Foumier A, et al. chamcterization and localization of vasoactive intestinal peptide receptors in the rat lung. Endocrinal. 1984;114(5):1506–12.CrossRef

15.

Foster N, Hulme SD, Barrow PA. Vasoactive intestinal peptide (VIP) prevents killing of virulent and phoP mutant Salmonella typhimurium by inhibiting IFN-gamma stimulated NADPH oxidative pathways in murine macrophages. Cytokine. 2006;36(3–4):134–40.PubMedCrossRef

16.

Said SI, Dickman K. Pathways of inflammation and cell death in the lung: modulation by vasoactive intestinal peptide. Regul Pept. 2000;93:21–9.PubMedCrossRef

17.

Onoue S, Ohmori Y, Endob K, Yamada S, Kimura R, Yajima T. Vasoactive intestinal peptide and pituitary adenylatecyclase activating polypeptide attenuate the cigarette smoke extract-induced apoptotic death of rat alveolar L2 cells. Eur J Biochem. 2004;271:1757–67.PubMedCrossRef

18.

Koh SW, Cheng J, Dodson RM, Ku CY, Abbondandolo CJ. VIP down-regulates the inflammatory potential and promotes survival of dying (neural crest-derived) corneal endothelial cells ex vivo: necrosis to apoptosis switch and up-regulation of Bcl-2 and N-cadherin. J Neurochem. 2009;109(3):792–806.PubMedCrossRef

Title: Role of Vasoactive Intestinal Peptide in Hyperoxia-Induced Injury of Primary Type II Alveolar Epithelial Cells
Authors: Xiaoxiao Ao
Fang Fang
Feng Xu
Publication date: 01-05-2011
Publisher: Springer-Verlag
Published in: Indian Journal of Pediatrics / Issue 5/2011
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI: https://doi.org/10.1007/s12098-010-0248-1

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Role of Vasoactive Intestinal Peptide in Hyperoxia-Induced Injury of Primary Type II Alveolar Epithelial Cells

Abstract

Objective

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2011

RETRACTED ARTICLE: Low Dose Lidocaine for Refractory Seizures in Preterm Neonates

Scorpion Sting Envenomation in Children: Factors Affecting the Outcome

Immune Reconstitution Syndrome in HIV-1 Infected Children—A Study from India

Determinants of Health Related Quality of Life in School-Going Adolescents in Northern India

Supratentorial PNET in a Young Child

Prevention of Iron Deficiency Anemia (IDA): How Far Have We Reached?